Second-Generation Antipsychotics Clinical Pharmacy Plan Developed from Hospital Pharmacy to Primary Health Care

Abstract

The growing role of hospital pharmacists in the ambulatory care setting challenges new changes. Drug distribution to Primary/Ambulatory Healthcare needs to reformulate a clinical pharmacy practice plan when presented with a patient having schizophrenia, according to criteria of rational drug use, equity and accessibility of the patient for sustained concentrations for several weeks indicated only for chronic therapy in patients who have trouble adhering to oral therapy that might achieve a markedly decline of positive, negative and cognitive symptoms. Therefore, these important features of long-acting injectable antipsychotics (LAIs, previously known as depot antipsychotics) need to be addressed on real-world practice. The purpose of the study is to develop drug distribution logistics for second-generation antipsychotics from Spanish Hospital Pharmacy to all Primary Health Care Sector (target population: Urban, Rural, and Homecare Support) from 2015 to 2016.